Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab
CompletedOBSERVATIONAL
Enrollment
50
Participants
Timeline
Start Date
June 30, 2016
Primary Completion Date
April 30, 2020
Study Completion Date
April 30, 2020
Conditions
Ulcerative Colitis
Trial Locations (1)
10676
Evangelismos Hospital, Athens
All Listed Sponsors
lead
Evangelismos Hospital
OTHER
NCT02868398 - Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab | Biotech Hunter | Biotech Hunter